The mRNA vaccine CDMO market is rapidly expanding, driven by growing biotech startups, limited in-house manufacturing, and ...
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.
That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...
The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...
Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...
In December 2025, Moderna submitted an application to the FDA to approve the first mRNA-based flu vaccine. Catherine Falls Commercial/Moment via Getty Images Ana Santos Rutschman, Villanova University ...
Among adolescents and young adults, cTnI levels remain within normal ranges after mRNA-1273 vaccination, with no evidence of increased myocardial injury.
Investigators sought to determine the long-term effects of COVID-19 infection and vaccination in patients with solid malignancies.
Postdoctoral fellow and co-first author Dongyoon Kim demonstrates some of the equipment used to craft the new ionizable lipids. [Bella Ciervo, Penn Engineering] The explosion of mRNA vaccines brought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results